Skip to content

Sideri Laboratory

Active
Private limited companyfounded 20206 yrs activeSteenweg 259/A, 9810 Nazareth, BelgiumKBO/BCE: BE 0746.552.085

The computed 12-month bankruptcy probability of Sideri Laboratory is 1.8% (moderate). The 2025 annual accounts show equity of €64k and a net result of €29k. Equity is growing by ~132.5% per year across the filed fiscal years. Its solvency ranks better than 61% of 1541 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
68 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability93▼-7
Solvency68▲+18
Growth78=
Track record100
Bankruptcy probability, 12 months
1.8% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity ample (current ratio 2.15 against 1.67 in 2024; short-term debt: 42.1% of total assets), but 56.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 6 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Sector 10
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
43.1%
Return on assets
19.5%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 23-01-2026, 8 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
8 d early
2024
32 d early
2023
19 d early
2022
42 d early
2021
40 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close20-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€64k▲ 68.1%
2024 · €38k
2021: €-15k 2022: €-19k 2023: €14k 2024: €38k
2021 → 2025
Total assets
€148k▼ 1.3%
2024 · €150k
2021: €90k 2022: €89k 2023: €101k 2024: €150k
2021 → 2025
Net result
€29k▼ 28.7%
2024 · €41k
2021: €-20k 2022: €-3k 2023: €32k 2024: €41k
2021 → 2025
Working capital
€72k▲ 45.2%
2024 · €49k
2021: €53k 2022: €18k 2023: €39k 2024: €49k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€-15k-€-19k▼ 22.0%€14k€38k▲ 174%€64k▲ 68.1%
Operating result€-12k-€-924▲ 92.3%€41k€54k▲ 33.8%€38k▼ 29.3%
Net result€-20k-€-3k▲ 83.4%€32k€41k▲ 24.9%€29k▼ 28.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-40k€-20k€0€20k€40k€60kOperating result 2021: €-12k€-12kNet result 2021: €-20k€-20kOperating result 2022: €-924€-924Net result 2022: €-3k€-3kOperating result 2023: €41k€41kNet result 2023: €32k€32kOperating result 2024: €54k€54kNet result 2024: €41k€41kOperating result 2025: €38k€38kNet result 2025: €29k€29k20212022202320242025
The operating result falls in 2025; 2025 is 29% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €148k
Fixed assets €14k▼ 47.7%
Current assets €134k▲ 8.9%
Equity and liabilities €148k
Equity €64k▲ 68.1%
Debt €84k▼ 24.9%
The debt ratio falls from 74.7% to 56.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€42k
2024 · €63k
Cash flow
€32k
2024 · €49k
Solvency
43.1%
2024 · 25.3%
Current ratio
2.15
2024 · 1.67
Quick ratio
1.31
2024 · 1.15
Debt / equity
1.32
2024 · 2.95
ROE
45.2%
2024 · 106.6%
ROA
19.5%
2024 · 27.0%
Interest coverage
21.38
2024 · 19.94
Debt
€84k
2024 · €112k
Debt ≤ 1 year
€62k
2024 · €74k
Debt > 1 year
€22k
2024 · €38k
Income taxes
€8k
2024 · €11k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€150k€148k
Fixed assets21/28€27k€14k
Intangible fixed assets21€2k€7k
Tangible fixed assets22/27€24k€5k
Plant, machinery and equipment23€1k€818
Furniture and vehicles24€18k€968
Other tangible fixed assets26€5k€3k
Financial fixed assets28€2k€2k=
Current assets29/58€123k€134k
Stocks and contracts in progress3€39k€52k
Stocks30/36€39k€52k
Amounts receivable within one year40/41€37k€81k
Trade receivables40€34k€73k
Other amounts receivable41€2k€8k
Cash at bank and in hand54/58€46k-
Deferred charges and accrued income490/1€2k€443
Equity and liabilities
Total equity and liabilities10/49€150k€148k
Equity10/15€38k€64k
Contributions10/11€5k€5k=
Reserves13€33k€59k
Distributable reserves133€33k€59k
Amounts payable17/49€112k€84k
Amounts payable after more than one year17€38k€22k
Financial debts170/4€38k€22k
Amounts payable within one year42/48€74k€62k
Current portion of amounts payable after more than one year42€25k€19k
Financial debts43-€10k
Credit institutions430/8-€10k
Trade debts44€31k€31k
Suppliers440/4€31k€31k
Taxes, remuneration and social security45€6k€100
Taxes450/3€6k€100
Other amounts payable47/48€12k€3k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€4k
Other operating charges640/8€992€1k
Gross operating margin9900€64k€43k
Operating profit (loss)9901€54k€38k
Financial income75/76B€32€343
Recurring financial income75€32€343
Financial charges65/66B€3k€2k
Recurring financial charges65€3k€2k
Profit (loss) for the period before taxes9903€51k€37k
Income taxes67/77€11k€8k
Profit (loss) for the period9904€41k€29k
Profit (loss) for the period to be appropriated9905€41k€29k
Appropriation of the result
Profit (loss) to be appropriated9906€41k€29k
Transfer from equity791/2€9k-
Transfer to equity691/2€33k€26k
To other reserves6921€33k€26k
Profit to be distributed694/7€16k€3k
Return on contributions (dividend)694€9k€3k
Directors or managers695€8k-

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
23-01
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2024
30-12
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
30-06
Financial Highest result since 2021net €41k ▲24.9%
Operating result €54k, net result €41k, both a record.
12-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial Back to profitnet €32k
Net result €32k after 2 loss-making years.
2022
20-12
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2021
22-12
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nazareth · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Steenweg 259/A9810 Nazareth
Ground area
967 m²
Building footprint
394 m²
Volume, LiDAR
1,618 m³
Parcel 44018B0308/00M002, Flanders · tallest building 8.4 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Sideri Laboratory
Steenweg 259, 9810 NazarethManufacture of food products
since 20182.276.620.286
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44018B0308/00M002 Flanders 967 m² 1 · 394 m² 8.4 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Nazareth2.276.620.286
1 permission
Toelating · Fabrikant voedingssupplementen · since 25-06-2018

Similar companies · same sector, comparable size

Of 395 companies in sector 10890 we hold annual accounts for 225. 110 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded28-04-2020
Fiscal year end30-06
Activities, NACEBEL
10890Manufacture of food products
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
68110Buying and selling of own real estate
68201Renting and operating of own or leased residential real estate, excluding social housing
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.